
Institute for Drug Development
- About Us
-
Cancer Care
- Diagnosing Cancer
-
Our Cancer Programs
- Adolescent and Young Adult Cancer Program
- Blood Cancer & Hematological Malignancy Program
- Blood Disorder (Hematology) Program
- Breast Cancer Program
- Cancer Risk Reduction and Education Clinic
- Cardio-Oncology Program
- Cancer Genetics Program
- Childhood Cancer Survivorship Program
- Endocrine Tumor Program
- Eye Cancer Program
- Gastrointestinal (GI) Cancer Program
- Genitourinary Cancer Program
- Gynecologic Oncology Program
- Head and Neck Cancer Program
- Liver Tumor and Cancer Program
- Lung Cancer Program
- Neuro-Oncology (Brain Tumor) Program
- Neurofibromatosis Program
- Pediatric Neuro-Oncology Program
- Pediatric Oncology Program
- Pediatric Sarcoma Program
- Pediatric Thrombosis Program
- Radiation Oncology
- Sarcoma Cancer Program
- Skin Cancer Program
- Cancer Survivorship Program
-
Cancer Prevention and Screenings
- Cervical Cancer Screening Guidelines
- Colorectal Cancer Screening
- Endometrial (Uterine) Cancer Screening Guidelines
- Hepatitis and Cancer
- HPV Vaccine and Screenings
- Liver Cancer Guidelines
- Lung Cancer Screening
- Mammogram
- Ovarian Cancer Screening Guidelines
- Prostate Cancer Screening Guidelines
- Skin Cancer Screenings
- Sun and Skin Safety
- Tobacco Use and Cancer
- Cancer Treatments
- Cancer Types
- Clinical Trials and Research
- Donate and Volunteer
- Education
- Patients and Families
- Appointments
- Doctors and Locations
- Avanzando Caminos (Leading Pathways) Study
- Community Outreach and Engagement Program
- Estudio Avanzando Caminos (Leading Pathways)
We are one of the leading cancer drug development centers in the country. Our contributions to the field include more than 20 FDA-approved new drugs (therapeutics), with many more in development.
In some cases, novel drugs may be available to eligible patients through phase I clinical trials up to five years before the general public has access to them. Our capabilities are renewing hope in patients for whom standard treatments have not been successful.
About our Institute for Drug Development
Our drug development program was one of the first of its kind in South Texas. Nationally renowned cancer researchers specializing in therapeutics work alongside chemists and biologists to develop and test new cancer drugs. Meet our team.
Our expertise includes advanced medical training for future drug development leaders. Find out more about our education and training cores.
The Institute for Drug Development is one of our many research centers exploring new cancer treatments. Find out more about:
Phase I clinical trials at Mays Cancer Center
Phase I clinical trials answer scientific questions about dosing and side effects of new drugs. These studies are the earliest point at which new drugs are available to eligible patients. Phase I trials are only available through established drug development programs such as ours.
We are exploring new options, including immunotherapy and targeted therapy for many types of cancer. Find out more about clinical trials.
How the Institute for Drug Development is advancing cancer care
The cancer drug development process includes different research activities:
Drug discovery
Biologists and chemists evaluate the fine details of cancer cells to identify proteins responsible for their growth. This information helps us identify drug targets, elements within cells that respond to cancer drugs.
Drug development
We evaluate compounds, groups of chemical substances, for their ability to interact with drug targets. Our scientists screen thousands of compounds to identify a few hundred potential options.
Preclinical trials
Our researchers perform studies in animals to learn more about:
- How the body absorbs compounds within a new drug
- Appropriate dose
- Possible side effects
- Best way to give the drug, such as a pill or injection
Phase I clinical trials
After preclinical trials, we adjust the drug or dose to make sure it is safe. Phase I trials are eligible patients’ first opportunity to receive these drugs while under the careful watch of our experts. Get more information about our cancer clinical trials.
Explore Mays Cancer Center
Find out more about how our research programs are helping us advance cancer care in South Texas and across the country.
Learn more about our NCI designation
Our National Cancer Institute (NCI) cancer center designation brings leading research programs. It also extends the range of our clinical trial offerings, for eligible patients.
Meet our research team
Our research team includes cancer experts from different medical specialties and scientists who share a commitment to advancing care and outcomes.